National and Kapodistrian University of Athens
Μελέτη της έκφρασης των bcl-2 και p53 στα επιθηλιακά νεοπλάσματα του νεφρού
Abstract
dc:descriptionIt is widely known that the disorders of the action of genes that control apoptosis typically cause prolongation of the life of cells and increase the likelihood of malignant transformation. Their expression and prognostic significance has been reported in various neoplasms such as lung cancer, breast cancer and esophageal cancer.The family of bcl-2 genes, originally studied in lymphomas, includes critic regulators of apoptosis. The clinical expression of bcl-2 has been associated with increased resistance of tumour cells to chemotherapy and radiation action. Regulators of apoptosis also include the protein p53 which is a multifunctional protein regulating the integrity of the genome. The p53 protein also acts as a direct activator of genes that affect the repair of DNA. When the repairing of the damage is not possible, the p53 protein activates the mechanism of apoptosis in cells. Renal carcinoma presents special characteristics such as a variety of histological types and variable therapeutic responce to chemotherapy and irradiation.Aim of this study, was to investigate the prognostic significance of the expression of bcl-2 and p53, in renal adenocarcinomas, in correlation with the grade, type, stage and survival by an immunohistochemical method.In our study, 78 cases of renal cell adenocarcinomas examined during the decade 1999-2000. The histological features were correlated with the various clinical and pathological characteristics of the tumours. Mean patient’s age was 65.4 years and the men/women ratio was 3/2. Mean tumour size was 6.8 cams and the most common location was the upper left kidney lobe.76.9% cases were clear cell adenocarcinomas, and 55.8% grade II tumours. Bcl-2 immunostain was positive in 64.1% cases and p53 positive immunostain in 17.1%Statistical analysis of the relationship between the positive immunoreaction, stage, grade and type was significant and associated with death risk as follows: Patients with positive expression of p53 had 6.92 times greater risk compared with patients with negative expression of p53. Patients with T2- tumour had 3.59 times greater risk compared with patients who were at T1 stage. Patients in T3-T4 tumour had 13.74 times greater risk compared with patients who were at T1 stage. Patients with grade 3-4 tumours had 6.85 times greater risk compared with patients with grade 2.It appeared that the expression of p53 but not of bcl-2 protein is significantly related to survival. As a consequence, the statistical analysis of the results proposed a survival-related equation as follows: H(t;Z)=Ho(t) x exp(1,93 x expression of p53+1,28 x (stage:T2)+2,62 x(stage:T3-T4)+1,92 x (grade3-4).(H(t;Z)=hazard, Ho(t)=baseline hazard)This equation offers valuable information about the risk of death of patients with renal cell carcinoma. Specifically, the death risk at a certain time increases in relation to the expression of p53, the grade, and the stageIdentical mathematical model is not mentioned in the recent bibliography.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Filippidou-Giannopoulou, Anna
- Φιλιππίδου-Γιαννοπούλου, Άννα
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39114